Clinical Review

Management of Bleeding Complications in Patients with Cancer


 

Patients with cancer can have many hematologic complications. One of the most serious is bleeding, which can range in severity from laboratory abnormalities to life-threatening hemorrhage. The bleeding can be due to complications of the cancer, its therapy, or treatment for complications of cancer such as thrombosis. This manual discusses an approach to the cancer patient with bleeding, with a specific focus on issues such as coagulation defects, thrombocytopenia, and platelet dysfunction. Bleeding complications of specific cancers and their treatment will be discussed as well.

To read the full article in PDF:

Click here

Recommended Reading

Cancer treatment–induced cardiotoxicity greatly underappreciated
MDedge Hematology and Oncology
Who will get cancer treatment-induced cardiotoxicity?
MDedge Hematology and Oncology
A wonderful life
MDedge Hematology and Oncology
Congestive heart failure during induction with anthracycline-based therapy in patients with acute promyelocytic leukemia
MDedge Hematology and Oncology
Impact of aprepitant on emesis control, dose intensity, and recurrence-free survival in a population-based cohort of head and neck cancer patients receiving high-dose cisplatin chemotherapy
MDedge Hematology and Oncology
Chemotherapy-induced peripheral neuropathy and impact on quality of life 6 months after treatment with chemotherapy
MDedge Hematology and Oncology
Is choice of anesthesia during cancer surgery linked to outcome?
MDedge Hematology and Oncology
A round-up of ASCO’s 2013-2014 guideline releases, updates, and endorsements
MDedge Hematology and Oncology
Medicare beneficiaries in hospice care get better care, have fewer costs
MDedge Hematology and Oncology
FDA approves extended-release hydrocodone with abuse-deterrent features
MDedge Hematology and Oncology